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Abstract
Background: Interest in using plants for production of recombinant proteins such as monoclonal antibodies is
growing, but proteolytic degradation, leading to a loss of functionality and complications in downstream
purification, is still a serious problem.
Results: In this study, we investigated the dynamics of the assembly and breakdown of a human IgG1 antibody
expressed in plants. Initial studies in a human IgG transgenic plant line suggested that IgG fragments were present
prior to extraction. Indeed, when the proteolytic activity of non-transgenic Nicotiana tabacum leaf extracts was
tested against a human IgG1 substrate, little activity was detectable in extraction buffers with pH > 5. Significant
degradation was only observed when the plant extract was buffered below pH 5, but this proteolysis could be
abrogated by addition of protease inhibitors. Pulse-chase analysis of IgG MAb transgenic plants also demonstrated
that IgG assembly intermediates are present intracellularly and are not secreted, and indicates that the majority of
proteolytic degradation occurs following secretion into the apoplastic space.
Conclusions: The results provide evidence that proteolytic fragments derived from antibodies of the IgG subtype
expressed in tobacco plants do not accumulate within the cell, and are instead likely to occur in the apoplastic
space. Furthermore, any proteolytic activity due to the release of proteases from subcellular compartments during
tissue disruption and extraction is not a major consideration under most commonly used extraction conditions.
Background
Plants are being developed as a manufacturing platform
for a range of pharmaceutical proteins such as vaccines,
hormones and antibodies. They are attractive for a num-
ber of reasons, including low production costs, the abil-
ity to assemble and modify multimeric proteins such as
monoclonal antibodies (MAbs) and the ease of scalabil-
ity. However, heterologous (plant-expressed) proteins
often face significant yield losses due to proteolytic
breakdown, which has widely been thought to be related
to tissue homogenisation and protein extraction. There
are many reports in the literature of degradation pat-
terns manifesting as small fragments in gels and immu-
noblotting analyses [1-3]. Depending on the primary
sequence of the heterologous protein, the number of
susceptible sites and their accessibility to plant specific
proteases, plant-expressed proteins may undergo com-
plete proteolysis or partial trimming [4]. Antibodies are
often subject to a significant degree of breakdown with
between two to five major species (between Mr 40K and
Mr 160K) being reported under non-reducing conditions
for different antibodies expressed in Nicotiana tabacum
leaves [1-3,5-7]. As well as affecting the final yield of
target proteins, degradation results in a heterogeneous
mixture of recombinant proteins which may alter overall
biological activity as well as complicating purification
processes [8].
Plants produce proteases for a variety of reasons. Pro-
teases are involved in classical biological processes such
as plant development, disease resistance, and nutrient
remobilisation for reproductive processes [9,10]. In addi-
tion, the timing and levels of protease expression can be
viewed as markers for the senescence state of plants
[11]. Over 800 proteases are encoded within the genome
of Arabidopsis [10] and expressed in various tissues and
organelles. Proteases are abundant in various subcellular
compartments, including the vacuole [11] and the apo-
plast [10], the default destination for antibodies targeted
to the secretory pathway [12,13].
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It is widely believed that ex vivo degradation of the
antibody occurs during the extraction process, as a
result of proteases released during tissue and cell dis-
ruption [14,15] and several strategies have been used to
minimise this effect [15-17]. Most commonly, protease
inhibitors are added to extraction buffers but these are
expensive and therefore not economically viable for
extraction at large scale. Other methods to prevent
degradation of recombinant proteins have been pro-
posed. Attempts to identify and knock out major pro-
tease families have met with limited success [10].
Alternative approaches include confining expression of
proteins to selected cell compartments [18-20], targeting
transgene expression to tissues with low metabolic turn-
over [21,22], co-expression of a specific recombinant
protease inhibitor [15,23], or by fusion to stabilising pro-
tein domains [24]. These are complicated by the fact
that targeted proteases are often important for plant
development, the broad spectrum of potential protease
targets and compromises resulting from alternative in
planta targeting strategies.
The objective of this study was to determine whether
antibody degradation in transgenic plants is predomi-
nantly an intracellular or extracellular process and to
identify whether processes involved in tissue disruption
and protein extraction are indeed major contributors to
proteolytic degradation of antibodies.
Results
The proteolytic degradation pattern of recombinant MAb
2G12 extracted from N. tabacum is not significantly
affected by protease inhibition
Leaf samples from transgenic N. tabacum plants expres-
sing the human IgG1 MAb 2G12 were extracted in
PBS (pH 7.4) in the presence or absence of a cocktail of
protease inhibitors (Roche Protease Inhibitor Cocktail
supplemented with pepstatin A). Analysis was by wes-
tern blotting under non-reducing conditions (Figure 1),
using IgG1 heavy chain-specific antiserum (Panel A) or
light chain-specific antiserum (Panel B) for detection. A
human IgG1 MAb, used as a positive control (PC),
demonstrates a predominant band at Mr 150K
Figure 1 Western blot analysis of transgenic N. tabacum plants expressing MAb 2G12. Leaf discs from 2G12-expressing plants were
extracted in either PBS (-) or PBS supplemented with protease inhibitor cocktail (+) and incubated at room temperature for 24 hours. Proteins
were separated by 4-15% SDS-PAGE under non-reducing conditions. The proteins were blotted to nitrocellulose membranes and probed with
either anti-human IgG Fc-specific antiserum (Panel A) or anti-human  antiserum (Panel B). The positive control (PC) consists of the human
IgG1 (1 ng/lane). The asterisk indicates the fully assembled 2G12 antibody; lower case letters (a to i) indicate antibody fragments.
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(indicated with an asterisk) corresponding to fully
assembled antibody. In the plant samples, the corre-
sponding major band was always detected. A band at a
slightly lower molecular weight (Mr ≈140K) was also
detected in both anti-gamma and anti-kappa blots (Fig-
ure 1, Panels A and B; labelled a). Together with band b
(Mr 100K) and band d (Mr 75K), these were the only
major, lower molecular weight species detectable in the
anti-gamma blot. In comparison, at least nine bands of
lower molecular weight were observed in the anti-kappa
blot (Figure 1, Panel B) labelled (a-i). Since some of
these bands have molecular weights greater than Mr
25K (the expected size for free light chain), the presence
of heavy chain fragments is implied, even though no
corresponding fragments are observed in the anti-
gamma blot. This was a consistent finding and was also
observed when several other human gamma chain-speci-
fic antisera were used. Inclusion of a cocktail of protease
inhibitors in the extraction buffer did not significantly
affect the intensity of the Mr 150K band, or the pattern
of smaller bands on the western blots (compare lane 1
with lane 2 and lane 5 with lane 6).
Protein A/G affinity chromatography was used to
purify the antibody mixture (i.e., both fully assembled
and lower molecular weight fragments) from 2G12
extracts. These purified proteins were analysed by
Coomassie staining of SDS-acrylamide gels under
reducing conditions (Figure 2, Panel A). This figure
shows that the fully assembled 2G12 antibody and the
co-purified lower molecular weight species observed in
Figure 1, Panels A and B resolve into two major bands,
one of apparent molecular weight Mr ≈ 55K and the
other with Mr ≈ 25K (labelled H and L, respectively).
The relative molecular weights of these two species,
particularly when compared with the free heavy and
light chains in the reduced positive control (PC) pro-
vide evidence that these 2G12 plant-derived bands are
free heavy and free light chains. This is supported by
their immunoreactivity with human Fc fragment-speci-
fic antiserum (Figure 2, H in Panel B) or human kappa
chain-specific antiserum (Figure 2, L in Panel C). In
addition, five breakdown fragments (labelled a, b, c, d
and e) are also observed. Two of these fragments (a
and d) appear to correspond to bands seen in the
Figure 2 Analysis, under reducing conditions, of purified 2G12. 2G12 and antibody fragments from plant extracts were purified using
Protein A/G affinity chromatography. Samples were reduced and separated by SDS-PAGE. In Panel A, separated proteins (15% gel) were
detected with Coomassie staining. The positive control (PC) consists of 500 ng/lane of human IgG1. The positions of free heavy and light
chains are indicated by H and L, respectively. In Panels B and C, separated proteins (4-15% gradient gels) were blotted to nitrocellulose
membranes and probed with either human Fc-specific antiserum (Panel B) or anti-kappa antiserum (Panel C). The positions of the free heavy (H)
and light (L) chains are indicated, while the lower molecular weight species labelled a to e indicate antibody fragments.
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Coomassie-stained gel. Fragments b (Mr ≈ 35K), c (Mr
≈ 23K) and e (Mr ≈ 11K) could only be detected with
the human Fc-specific antiserum (Panel B). Band d
(Mr ≈ 12K) was only reactive with the kappa chain-
specific antiserum (Panel C).
N. tabacum leaf extracts at neutral pH exhibit little
proteolytic activity against IgG
The presence of the majority of immunoglobulin frag-
ments in plant extracts prepared with protease inhibitor
cocktail suggested that proteolytic degradation might
occur predominantly in planta prior to extraction. In
order to investigate the influence of proteases released
during the extraction process, we used Nicotiana taba-
cum leaf extracts from non-transgenic plants, prepared
in either PBS (pH 7.4) or PBS supplemented with a pro-
tease inhibitor cocktail, to which a standard amount of a
human IgG1 MAb was added. Samples were incubated
for either 15 mins, 2 hrs or 24 hrs at room temperature
and analysed by western blotting (Figure 3), using an
anti-gamma chain antiserum (Panel A) or anti-kappa
chain antiserum (Panel B).
The commercial MAb preparation consists of a predo-
minant single band (labelled with an asterisk) at the
expected Mr of ≈ 180K (Lane PC). The smaller frag-
ments (bands labelled a and b) were also evident in
both anti-heavy and anti-light chain blots.
This pattern of bands was not significantly affected by
incubation with the tobacco extract for up to 24 hrs.
The intensities of these bands did not vary over time.
Moreover, the addition of the cocktail of protease inhi-
bitors had no significant effect at any of the time points.
A faint band (Mr ≈ 120K, labelled c) was observed on
some blots due to specific blotting conditions. This
band is unlikely to be the result of proteolytic degrada-
tion in the plant extract as it is also present in the posi-
tive control lanes in Figure 4 Panels A-C.
IgG proteolysis by tobacco plant extracts is activated at
acidic pH
In the next experiment, the influence of extraction buf-
fer pH on the proteolytic activity of N. tabacum leaf
extracts was investigated. Leaf tissue was extracted in
buffers at different pH and incubated at room tempera-
ture with exogenous human IgG. Samples were taken
after 15 mins, 2 hrs or 24 hrs and analysed by SDS-
PAGE and western blotting using an anti-gamma chain
antiserum (Figure 4, Panels A-C). The results showed
that at pH > 6, there was no significant change in the
intensity of the intact IgG (labelled with an asterisk).
The smaller bands a, b and c (all present this time in
the control sample) did not alter in intensity with
decreasing pH. This is true for all the time points inves-
tigated (Figure 4, Panels A-C). At pH 5, the intensity of
band a increased at all three time points. When the pH
was reduced further to 4.2 or 3, a dramatic loss of
immunoreactive material occurred, even at the 15 mins
time point.
In order to verify whether pHs < 5 might be responsi-
ble for the activation of proteases present in N. tabacum
leaf extracts, we compared IgG samples that were incu-
bated with plant extracts at pH 7.4, pH 4.2 or pH 3, in
the presence or absence of a protease inhibitor cocktail.
Samples were incubated for 24 hrs and analysed by wes-
tern blotting using an anti-human Fc antiserum (Figure
4, Panel D) or anti-human light chain antiserum (Figure
4, Panel E). In the absence of protease inhibitors, no sig-
nificant degradation was seen at pH 7.4, but extensive
antibody degradation was observed at pH 4.2 and pH 3,
as before. However, addition of the protease inhibitor
cocktail almost completely abrogated the antibody loss
at low pH.
As pH affected the proteolytic activity of tobacco leaf
extracts on exogenous IgG, the effect of extraction buf-
fer pH on MAb 2G12 expressed in transgenic plants
was examined. Leaf discs were extracted in different pH
buffers as before and incubated for 15 mins or 24 hrs at
room temperature. Samples were analysed by SDS-
PAGE and western blotting. Immunoreactive bands
were detected with anti-kappa antiserum (Figure 5).
Recombinant antibody extracted under these conditions
was already extensively degraded, as previously observed
in Figure 1, but between pH 5-8, there was little differ-
ence between the analysed samples, either after 15 mins
(Figure 5, Panel A) or 24 hrs incubation (Figure 5, Panel
B). At pH 4.2 and pH 3, there was extensive degradation
of the antibody. Interestingly, the loss of intact IgG is
not associated with the appearance of new degradation
bands or increased intensity of existing degradation pro-
ducts, rather it appears that there is complete loss of
immunoreactivity of all bands.
Analysis of MAb 2G12 fragments and secretion in
transgenic plant cells
Protoplasts prepared from MAb 2G12 transgenic plants
were pulse-labelled for 30 mins, and subsequently chased
following the addition of cold amino acids over a period
of 4 hours. During the chase, samples were taken at 0
hrs, 1 hour, 2 hrs and 4 hrs, immunoprecipitated and
visualised by SDS-PAGE and auto-radiography to investi-
gate secretion and degradation of MAb 2G12 under non-
reducing conditions (Figure 6, Panel A) and reducing
conditions (Figure 6, Panel B). Intact MAb 2G12 (indi-
cated with an asterisk) was identified in the protoplasts at
0 hrs. The amount of intact MAb diminished with time
inside the protoplasts, concomitant with a gradual
increase in full length MAb in the medium. This indi-
cates efficient secretion of MAb 2G12, as has been
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Figure 3 Western blot analysis of exogenous human IgG1 incubated with wild type N. tabacum leaf extract with or without protease
inhibitor cocktail. Leaf discs from wild type N. tabacum plants were extracted in either PBS (-) or PBS supplemented with a protease inhibitor
cocktail (+) and exogenous human IgG1 (1.8 ng/lane) was added. The mixtures were incubated at room temperature for the indicated times
and proteins separated by 6% SDS-PAGE under non-reducing conditions. The proteins were blotted onto nitrocellulose and probed with anti-
human g1 (Fc region specific) antiserum (Panel A) or anti-human  antiserum (Panel B). The control (PC), is a human IgG1 (1.8 ng/lane). The
asterisk indicates the fully assembled 2G12 antibody; lower case letters (a, b and c) indicate antibody fragments.
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described previously for another MAb [25]. The charac-
teristic pattern of smaller species (a, b, d, g, h and i) was
observed in the cellular samples. Three of these bands
(bands a, b and g) decreased in intensity over time,
whereas others seemed to be stable within the cell (bands
d, h and i). The result suggests that fully assembled MAb
2G12 is efficiently secreted from transgenic plant cells,
while smaller immunoreactive species of MAb 2G12 are
present intracellularly, remain in the cell and are not
secreted, with the exception of band d which was visible
after 2 hrs chase in the medium. Under reducing condi-
tions (Panel B) free heavy chain (indicated H, Mr ≈ 55K)
and free light chain (indicated L, Mr ≈ 25K) were the
only bands detected by radiolabelling.
To establish the pattern of antibody bands within the
cells under steady state conditions, unlabelled protoplasts
were prepared from leaf tissue of two month old trans-
genic plants expressing MAb 2G12 and analysed by SDS-
PAGE and western blotting under non-reducing (Panel
C) and reducing conditions (Panel D). For each condi-
tion, these results were compared to the pattern obtained
from a crude extract of the same leaf material. At steady
state, free heavy or light chain were again the only bands
detected under reducing conditions within the cells,
whereas several additional fragments could be observed
in the crude extract. The presence of bands that did not
correspond to assembly intermediates was also apparent
in the non-reduced crude sample (Panel C).
Discussion
Many recombinant MAbs extracted from transgenic
plants demonstrate a characteristic and reproducible
pattern of fragmentation. Such a pattern was observed
in the MAb 2G12 plants studied here. Despite findings
which show that recombinant protein degradation
occurs in vivo [25,26], the possibility that degradation
fragments are formed as a result of proteases that are
activated during plant cell and tissue disruption cannot
be excluded [14]. As a consequence, it is routine prac-
tice to include a range of protease inhibitors in extrac-
tion buffers. However, the efficacy of protease inhibitors
has never been proven, furthermore they are frequently
expensive and unlikely to be practical for commercial
scale up.
Figure 4 Western blot analysis of protease-activity in wild type N. tabacum leaf extracts of different pH. Human IgG1 was mixed with
wild-type N. tabacum leaf extracts buffered at pH 3.0, 4.2, 5.0, 6.2, 7.4 or 8.0 and incubated at room temperature for 15 mins (Panel A); 2 hrs
(Panel B); or 24 hrs (Panel C). Proteins were separated by 6% SDS-PAGE under non-reducing conditions. The proteins were blotted onto
nitrocellulose and probed with anti-human g1 (Fc region specific) antiserum. PC is the positive control human IgG1 (1.8 ng/lane). For three of
the pH conditions, the effect of a protease inhibitor cocktail was tested (± PI, Panels D and E). Samples were tested at 24 hrs and
immunodetection was with anti-heavy chain antiserum (Panel D) or anti-light chain antiserum (Panel E). The asterisk indicates the fully
assembled 2G12 antibody; lower case letters (a, b and c) indicate antibody fragments.
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Figure 5 Western blot analysis of recombinant MAb 2G12 extracted from transgenic N. tabacum in different pH-buffers. Leaf discs from
MAb 2G12-expressing plants were extracted in solutions buffered to; pH 3.0, pH 4.2, pH 5.0, pH 6.2, pH 7.4, or pH 8.0. The mixtures were
incubated at room temperature for 15 mins (Panel A) or 24 hrs (Panel B). Proteins were separated by SDS-PAGE under non-reducing conditions.
Proteins were blotted onto nitrocellulose membranes and probed with anti-human  antiserum. The asterisk corresponds to the fully assembled
2G12 antibody, while the lower case letters (a to j) indicate antibody fragments.
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The identity of the IgG fragments has also not yet
been determined. Whilst some may represent assembly
intermediates of IgG (e.g., free heavy or light chains, H/
L heterodimers or H/H homodimers), these cannot
account for all of the fragments observed. Indeed, when
analysed under reducing conditions (Figure 2), frag-
ments with a lower molecular weight than the free
heavy and free light chains were observed and these can
only be due to degradation. Based on the data pre-
sented, tentative assignments have been made for each
of the bands observed in Figure 1B. Species which cor-
respond to bands present in the protoplast preparation
(Figure 6, Panel D) are likely to be assembly intermedi-
ates (bands a, b, d, g and i in both figures), as no other
fragments were observed in protoplasts under reducing
conditions. Band g shares a molecular weight (Mr 50K)
with a species previously described as a degradation
fragment (Fab-like fragment) [3,5,27]. This possibility
cannot be excluded as the predicted mobility of both
components of a reduced Fab-like fragment matches
that of the light chain. Bands c, e, f and h in Figure 1B
were present only in the plant tissue extract (Figure 6,
Panel C), and are likely to originate in the apoplastic
space as they were not affected by the addition of
Figure 6 Pulse chase analysis of antibody fragments in MAb 2G12 transgenic plant cells. Protoplasts from leaves of transgenic tobacco
plants expressing the MAb 2G12 were washed and analysed by SDS-PAGE and western blotting (Panels C and D) or pulse-labelled for 1 hr and
chased for the indicated periods of time (Panels A and B). Extracellular medium samples and homogenised cells were subjected to
immunoprecipitation with Protein G/Protein A mix. Immunoprecipitated proteins were analyzed by SDS-PAGE and radiography. The asterisk
corresponds to the fully assembled 2G12 antibody, while the lower case letters (a to i) indicate antibody fragments. Panels A and C were
performed under non-reducing conditions, whereas samples in Panels B and D were reduced with the addition of 5% b-mercaptoethanol prior
to boiling.
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protease inhibitor (Figure 1, Panel B) and are not appar-
ent in the protoplast preparation (Figure 6, Panel C).
The loss of plant-expressed antibodies due to proteo-
lytic degradation ex planta and in planta is a major
concern regarding stability, final yield of plant-expressed
MAbs and validation of purification. Development of
strategies to prevent proteolytic degradation of plant-
expressed antibodies would therefore be a worthwhile
consideration, so it is important to understand when
and where this degradation occurs.
Non-transgenic N. tabacum leaf extracts have little or
no anti-IgG proteolytic activity in the pH range com-
monly used for experimental extraction. In addition, the
use of a broad acting cocktail of protease inhibitors at
high concentration had little effect on the IgG fragment
pattern for MAb 2G12. These findings suggest that
degradation of MAb 2G12 is not related to the process
of extraction, more likely, degradation occurs before
extraction, and either along the secretory pathway, in
the apoplastic space, or in subcellular storage compart-
ments [28]. These observations support the findings of
Hassan et al. [29] who showed little benefit from using
protease inhibitors during the extraction of a murine
IgG1 at neutral pH to prevent the loss of functional
MAb. Endoproteases that can degrade monoclonal anti-
bodies are undoubtedly released during the extraction
process [17,30,31], but significant proteolytic activity
was only observed here at pH < 5 and in this instance,
degradation could be countered by the protease inhibi-
tor cocktail.
At low pH, degradation of IgG is characterised by a
complete loss of MAb, rather than the appearance of
new, smaller species. An explanation for this phenom-
enon could be that plant proteases active in acidic con-
ditions (e.g. aspartic acid proteases) may show extensive
activity on antibody Fc regions, degrading it to smaller
peptides [32,33]. Kim et al. [34] suggested that under
acidic conditions (pH 3.9) a conformational change in
the Fc region of an IgG takes place, which makes the
antibody more accessible to proteases.
The organelles of the early secretory pathway are the
sites of initial polypeptide folding and maturation. Given
these roles, the luminal compartments of these orga-
nelles are not widely recognised as possessing broad-
spectrum proteolytic activity. The established paradigm
for ‘quality control’ in the ER consists of prolonged
association with ER-resident chaperones, N-glycan mod-
ification, retrotranslocation and complete degradation by
the proteasome in the cytosol [35,36]. Alternative routes
for luminal disposal of proteins that fail to mature have
been mooted, either through trafficking in a complex
with BiP to the vacuole [37] or via an ER subdomain
rich in proteases [38]. It is important to remember that
antibodies have not evolved in the context of the plant
protease degradome, and they could therefore represent
novel targets for plant proteases [14]. However, previous
studies on transgenic tobacco tissue have shown that by
blocking early transport events in the secretory pathway,
and thereby causing an accumulation of antibody in an
ER-Golgi super-compartment, the accumulation of
intact mouse IgG1 MAb could in fact be markedly
improved [2]. High levels of intact recombinant protein
have been reported to accumulate in ER-derived com-
partments, such as protein bodies [39].
Here, we have shown that IgG-expressing protoplasts
do not accumulate MAb proteolytic fragments when ana-
lysed at steady state. Furthermore, a discrete pulse of
expression analysed over a 4-hour chase period revealed
no species that did not correspond to the predicted
mobility of an IgG assembly intermediate. Hence, it
would appear unlikely that discrete intracellular proteoly-
tic fragments are not detectable at steady state due to
rapid clearance through further degradation. In similar
pulse-chase experiments, Hadlington et al. describe the
formation of fragments characteristic of vacuolar proteo-
lysis when a hybrid murine MAb with both gamma and
alpha constant regions was expressed in protoplasts [40].
These fragments were not observed in our experiments.
Over the course of the chase, several smaller species are
lost from the protoplasts apparently without fragmenta-
tion or secretion into the medium, which suggests that a
significant proportion of IgG tetramers undergo a
delayed assembly. The cause of this slow assembly is
unclear, although it has been reported that an excess of
light chain may be required for efficient release of heavy
chain from the heat shock protein 70 (HSP70) family
chaperone BiP [41], and no attempt was made here to
optimise the stoichiometry of the components.
In contrast to the secretory pathway, the apoplast is a
likely compartment for the formation and accumulation
of the proteolytic fragments observed in these experi-
ments. The pH of apoplastic fluid is between pH 5-6
[42]. The apoplastic space is regarded to be rich in
acidic proteases [6,7] and a number of candidate pro-
teases have been identified. Secretion of six proteases
into the leaf apoplastic space of different plant species
(tomato, Arabidopsis, N. benthamiana), belonging to the
cysteine protease (papain-like), aspartic protease (pep-
sin-like) and serine protease (subtilisin-like and carboxy-
peptidase-like) families has been reported [10].
Seventeen peptides corresponding to predicted plant
aspartic, cysteine, and serine proteases were identified
from zymography of intercellular fluid from N. tabacum
[43]. A plasma membrane associated metalloproteinase
has recently been reported in tobacco cells [44], and a
member of the legumain Asn-specific cysteine endopep-
tidase family has also been described in the plant cell
wall [45].
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Conclusions
We conclude that the fragmentation pattern of heterolo-
gously expressed MAb in N. tabacum is not primarily
due to proteolysis arising during extraction unless acidic
extraction buffers are used. Instead, the fragmentation
pattern observed when samples are subjected to SDS-
PAGE under reducing conditions appears to reflect in
planta proteolysis, and this activity was restricted to the
apoplast rather than the cells. If this is the case, it is
unlikely that any extraction strategy that utilises exogen-
ous measures to control proteolytic degradation will
have a significant effect. Measures aimed at preventing
degradation of IgG within the apoplastic space have the
potential to increase yield and homogeneity of this




Nicotiana tabacum (var. xanthi) plants (2-3 months old)
were used. They were either wild-type (non-transgenic)
or transgenic and homozygous for the g and  chains of
the human IgG1 MAb 2G12 (kindly provided by Tho-
mas Rademacher and Eva Stöger). For each sample, a
single leaf disc (average mass = 7.56 mg) was excised
from a young leaf using the lid of a 1.5 ml Eppendorf
tube as a punch. Leaf discs were homogenised using a
plastic pestle in a 1.5 ml microcentrifuge tube and incu-
bated with 300 μl of the appropriate extraction buffer.
Antibody stability in crude plant extracts
A range of extraction buffers at different pHs were used for
the extraction. These were phosphate buffered saline (PBS)
at pH 7.4; 0.1 M citric acid-phosphate buffer at pH 3.0, 4.2,
5.0, or 6.2, or 50 mM Tris-HCl buffer at pH 8.0. In some
cases, where indicated, the extraction buffer was supple-
mented with 7x Complete® Protease Inhibitor Cocktail
(Roche, UK) and 7 mg/ml pepstatin A (Sigma, UK).
Extracted samples were centrifuged for 5 mins at 17
000 × g and the supernatant collected.
For experiments involving supplemented (exogenous)
antibody, a human IgG1 MAb (The Binding Site, UK)
was added to wild type plant extracts to a final concen-
tration of 0.2 ng/μl. Samples were incubated for 15
mins, 2 hrs or 24 hrs at room temperature, before being
analysed by SDS polyacrylamide gel electrophoresis
(SDS-PAGE) and western blotting.
Protein purification
Transgenic N. tabacum plants expressing 2G12 MAb
were ground in PBS (pH 7.4). The homogenate was cen-
trifuged for 30 mins at 15 000 × g, 10°C, the supernatant
filtered through No. 3 Whatman paper, the pH adjusted
to 7.6 and incubated on ice for 30 mins. The sample
was centrifuged again (17 0000 × g, 30 mins, 10°C) and
the supernatant was filtered (0.22 μm, Millipore) and
loaded onto a mixed Protein G-Sepharose (Sigma,
P3296)/Protein A-Agarose (Sigma, P3476) column. The
column was washed with PBS, antibody eluted with 100
mM glycine (pH 2.5) and the pH of the eluate neutra-
lised with 1 M Tris base (pH unadjusted).
SDS-PAGE and western blotting
Protein samples were separated on either 15% polyacry-
lamide gels under reducing conditions, 6% polyacryla-
mide gels or 4-12% Bis-Tris gradient gels (Invitrogen)
under non-reducing conditions. Aliquots (60 μl) of the
processed samples were boiled for 3 mins with 15 μl of
5x SDS-PAGE sample buffer, (50% (v/v) glycerol, 10%
(v/v) sodium dodecylsulfate, 0.3125 M Tris-HCl (pH
6.8) and 0.125% (w/v) bromophenol blue) for analysis
under non-reducing conditions, or supplemented with
b-mercaptoethanol to 5% (v/v) for analysis under redu-
cing conditions. As a control in the western blotting, a
human IgG1 MAb (The Binding Site, UK) was loaded
at either 1 ng/lane or 1.8 ng/lane. Separated proteins
were blotted onto nitrocellulose membranes using a
semi-dry transfer device (BioRad). The membranes were
incubated with 5% (w/v) non-fat milk powder in TBS
for at least 30 mins to block free protein binding sites.
A polyclonal HRP-labelled goat anti-human IgG (Fc
fragment) antiserum (Jackson ImmunoResearch, 109-
035-008) was used for detection of the heavy chain.
Detection of the light chain was performed with an
HRP-labelled anti-human kappa () reagent (Sigma,
A7164). Blots were washed five times with PBS contain-
ing 0.2% (v/v) Tween 20 and developed using the ECL
Plus western blotting detection system (GE Healthcare).
For Coomassie staining, Protein A/G purified plant
samples were separated on SDS-acrylamide gels under
reducing conditions (5x SDS-PAGE sample buffer sup-
plemented with 5% (v/v) 2-mercaptoethanol) and incu-
bated for 1 hr with Coomassie InstantBlue (Expedeon).
A human IgG1 MAb (The Binding Site, UK), used as a
positive control (PC), was loaded at 500 ng/lane.
Preparation of protoplasts and in vivo labelling
Leaves from 4-6 week old transgenic N. tabacum plants
expressing MAb 2G12 were used for the preparation of
protoplasts as described in Pedrazzini [46] and incu-
bated for 16 hrs in 4% (w/v) Cellulase Onozuka R-10,
2% (w/v) Macerozyme Onozuka R-10 (Apollo Scientific),
in K3 medium (Gamborg’s B5 basal medium with mini-
mal organics, 3.78 g/L; supplemented with 750 mg/L
CaCl2.2H2O; 250 mg/L NH4NO3; 136.2 g/L sucrose; 250
mg/L xylose; 1 mg/L 6-benzylaminopurine; and 1 mg/L
a-naphthalene acetic acid, pH 5.5) at 25°C in the dark.
Tissue disruption and recovery of viable protoplasts was
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in K3 medium. The radiolabelling period (50 μCi/ml
Expre35S35S cell labeling mix (73% L-[35S]methionine
and 22% L-[35S]cysteine; Perkin Elmer, Beaconsfield,
UK) was for 30 mins and the chase was started with the
addition of excess cold amino acids (time point 0 h).
Samples were taken at 0 hours, 1 hour, 2 hours and 4
hours after labelling and protoplast were precipitated by
the addition of three volumes of W5 medium (154 mM
NaCl, 5 mM KCl, 125 mM CaCl2.2H2O, and 5 mM glu-
cose). Samples were homogenized in homogenisation
buffer (150 mM Tris-HCl, pH 7.5; 150 mM NaCl; 1.5%
(v/v) Triton X-100) or 2 volumes of the same buffer
containing 0.25% (w/v) gelatin, respectively; supplemen-
ted with one tablet of Complete Protease Inhibitor
Cocktail (Roche) per 15 ml). Immunoprecipitation of
labeled samples was performed as described in Pedraz-
zini [46] with a mix of Protein A-Agarose beads (Sigma)
and Protein G-Sepharose beads (Sigma) in NET buffer
(50 mM Tris-HCl, pH 7.5; 150 mM NaCl; 1 mM EDTA;
0.1% (v/v) Nonidet P-40). After removal of the superna-
tant, immunoprecitated polypeptides were either stored
frozen at -20°C or immediately analysed by reducing or
non-reducing SDS-PAGE on 4-15% gradient gels. Gels
were fixed for 30 mins in 10% (v/v) acetic acid, 40% (v/
v) ethanol and amplified for 20 mins using NAMP100
(GE Healthcare), followed by autoradiography.
List of abbreviations
Fc: Fragment crystallizable; HRP: horseradish peroxidase; hrs: hours; IgG:
Immunoglobulin G; MAb: Monoclonal antibody; mins: minutes; PBS:
phosphate-buffered saline; Mr: relative molecular mass; SDS-PAGE: sodium
dodecylsulfate-polyacrylamide gel electrophoresis; TBS: Tris-buffered saline.
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